CD8A and neoplasm: More importantly, disruption of LTΒR in TAMs hinders tumor growth and even enhance the efficacy of immunotherapy through reversing TAM‐mediated immunosuppression, for instance, boosting CD8+ T cells and repressing G‐MDSC as well as M2‐like TAMs (Figure 5).